Literature DB >> 7946798

Role of ACE inhibitors in uncomplicated essential hypertension.

J I Robertson1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7946798      PMCID: PMC1025588          DOI: 10.1136/hrt.72.3_suppl.s15

Source DB:  PubMed          Journal:  Br Heart J        ISSN: 0007-0769


× No keyword cloud information.
  55 in total

1.  The response of blood pressure to infusion of angiotensin II: relation to plasma concentrations of renin and angiotensin II.

Authors:  R H Chinn; G Düsterdieck
Journal:  Clin Sci       Date:  1972-04       Impact factor: 6.124

2.  Fusion of cultured multiple-sclerosis brain cells with indicator cells: presence of nucleocapsids and virions and isolation of parainfluenza-type virus.

Authors:  V ter Meulen; H Koprowski; Y Iwasaki; Y M Käckell; D Müller
Journal:  Lancet       Date:  1972-07-01       Impact factor: 79.321

3.  Captopril, enalapril, and quality of life.

Authors:  J E Ware
Journal:  N Engl J Med       Date:  1993-08-12       Impact factor: 91.245

4.  Captopril, enalapril, and quality of life.

Authors:  A Fletcher
Journal:  N Engl J Med       Date:  1993-08-12       Impact factor: 91.245

5.  On the assertion that a moderate restriction of sodium intake may have adverse health effects.

Authors:  H E de Wardener; N M Kaplan
Journal:  Am J Hypertens       Date:  1993-09       Impact factor: 2.689

6.  The effects of the angiotensin II antagonist saralasin on blood pressure and plasma aldosterone in man in relation to the prevailing plasma angiotensin II concentration.

Authors:  J J Brown; W C Brown; R Fraser; A F Lever; J J Morton; J I Robertson; E A Rosei; P M Trust
Journal:  Prog Biochem Pharmacol       Date:  1976

7.  Management guidelines in essential hypertension: report of the second working party of the British Hypertension Society.

Authors:  P Sever; G Beevers; C Bulpitt; A Lever; L Ramsay; J Reid; J Swales
Journal:  BMJ       Date:  1993-04-10

8.  Comparison of captopril, hydralazine and nifedipine as third drug in hypertensive patients.

Authors:  E G Bevan; S D Pringle; P C Waller; A L Herrick; J G Findlay; G D Murray; H A Carmichael; J L Reid; R J Weir; A R Lorimer
Journal:  J Hum Hypertens       Date:  1993-02       Impact factor: 3.012

9.  Neurohormonal and metabolic effects of severe and moderate salt restriction in non-obese normotensive adults.

Authors:  M Ruppert; A Overlack; R Kolloch; K Kraft; B Göbel; K O Stumpe
Journal:  J Hypertens       Date:  1993-07       Impact factor: 4.844

10.  Plasma renin activity and ischemic heart disease.

Authors:  T W Meade; J A Cooper; W S Peart
Journal:  N Engl J Med       Date:  1993-08-26       Impact factor: 91.245

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.